Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-363.9%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.78Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information
Ticker
XLOCompany Name
XILIO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXILIO THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XLO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -54.59M | -363.9% | $ 15M |
| 3/31/2025 | $ -52.6M | -567.23% | $ 9.27M |
| 12/31/2024 | $ -56.6M | -892.13% | $ 6.34M |
| 9/30/2024 | $ -61.09M | -1322.19% | $ 4.62M |
| 6/30/2024 | $ -63.73M | -2704.03% | $ 2.36M |
| 3/31/2024 | $ -69.12M | 0% | $ 0 |
| 12/31/2023 | $ -74.5M | 0% | $ 0 |
| 9/30/2023 | $ -79.28M | 0% | $ 0 |
| 6/30/2023 | $ -82.3M | 0% | $ 0 |
| 3/31/2023 | $ -87.61M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, XILIO THERAPEUTICS INC's average EBITDA % has been -1169.9%.
- The median EBITDA % for XILIO THERAPEUTICS INC during this period was -892.13%
- XILIO THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -363.9%.
- The lowest EBITDA % recorded by XILIO THERAPEUTICS INC in the same timeframe -2704.03%
XILIO THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for XILIO THERAPEUTICS INC is calculated as follows: EBITDA [ $ -54.15M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] XLO - EBITDA Margin, Last 5 years
-2704.03%
Minimum
Jun 30, 2024
-363.9%
Maximum
Jun 30, 2025
-1169.9%
Average
-892.13%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |